Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines

References

• ESH/ESC Task Force for the Management of Arterial Hypertension2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial HypertensionJ Hypertens201331101925193824107724
   PubMed Web of Science ®Google Scholar
• JamesPAOparilSCarterBL2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)JAMA2014311550752024352797
   PubMed Web of Science ®Google Scholar
• ZanchettiAGrassiGManciaGWhen should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisalJ Hypertens200927592393419381107
   PubMed Web of Science ®Google Scholar
• BeckettNSPetersRFletcherAETreatment of hypertension in patients 80 years of age or olderN Engl J Med2008358181887189818378519
   PubMed Web of Science ®Google Scholar
• JATOS Study GroupPrincipal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS)Hypertens Res200831122115212719139601
   PubMed Web of Science ®Google Scholar
• OgiharaTSarutaTRakugiHTarget blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension studyHypertension201056219620220530299
   PubMed Web of Science ®Google Scholar
• ZhangYZhangXLiuLZanchettiAIs a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trialEur Heart J201132121500150821345850
   PubMed Web of Science ®Google Scholar
• YusufSDienerHCSaccoRLTelmisartan to prevent recurrent stroke and cardiovascular eventsN Engl J Med2008359121225123718753639
   PubMed Web of Science ®Google Scholar
• PittBByingtonRPFurbergCDEffect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT InvestigatorsCirculation2000102131503151011004140
   PubMed Web of Science ®Google Scholar
• Poole-WilsonPALubsenJKirwanBAEffect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trialLancet2004364943784985715351192
   PubMed Web of Science ®Google Scholar
• BraunwaldEDomanskiMJFowlerSEAngiotensin-converting-enzyme inhibition in stable coronary artery diseaseN Engl J Med2004351202058206815531767
   PubMed Web of Science ®Google Scholar
• ArguedasJALeivaVWrightJMBlood pressure targets for hypertension in people with diabetes mellitusCochrane Database Syst Rev201310CD00827724170669
   PubMed Web of Science ®Google Scholar
• ArguedasJAPerezMIWrightJMTreatment blood pressure targets for hypertensionCochrane Database Syst Rev20093CD00434919588353
   PubMed Web of Science ®Google Scholar
• UpadhyayAEarleyAHaynesSMUhligKSystematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifierAnn Intern Med2011154854154821403055
   PubMed Web of Science ®Google Scholar
• National Clinical Guideline Centre (UK)Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34 InternetLondonRoyal College of Physicians (UK)2011 Available from: http://www.ncbi.nlm.nih.gov/books/NBK83274/Accessed July 31, 2015
   Google Scholar
• AronowWSFlegJLPepineCJACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of HypertensionJ Am Soc Hypertens20115425935221771565
   PubMed Web of Science ®Google Scholar
• WeberMASchiffrinELWhiteWBClinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of HypertensionJ Clin Hypertens (Greenwich)2014161142624341872
   PubMed Web of Science ®Google Scholar
• MalaccoEOmboniSVolpeMAuteriAZanchettiAESPORT Study GroupAntihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly patients with mild to moderate essential hypertension: the ESPORT studyJ Hypertens201028112342235020829713
   PubMedGoogle Scholar
• MallionJMOmboniSBartonJAntihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertensionBlood Press Suppl2011131121091270
   PubMedGoogle Scholar
• OmboniSMalaccoEMallionJMFabrizziPVolpeMOlmesartan vs ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studiesHigh Blood Press Cardiovasc Prev201421111924435506
   PubMedGoogle Scholar
• KereiakesDJNeutelJStoakesKAThe effects of an olmesartan medoxomil-based treatment algorithm on 24-hour blood pressure levels in elderly patients aged 65 and olderJ Clin Hypertens (Greenwich)200911841142119695028
   PubMed Web of Science ®Google Scholar
• SaitoIKushiroTHirataKThe use of olmesartan medoxomil as monotherapy or in combination with other antihypertensive agents in elderly hypertensive patients in JapanJ Clin Hypertens (Greenwich)200810427227918401224
   PubMed Web of Science ®Google Scholar
• HeagertyAMMallionJMOlmesartan medoxomil in elderly patients with essential or isolated systolic hypertension: efficacy and safety data from clinical trialsDrugs Aging2009261617619102515
   PubMed Web of Science ®Google Scholar
• OgawaHKim-MitsuyamaSMatsuiKAngiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patientsAm J Med20121251098199022503610
   PubMed Web of Science ®Google Scholar
• MallionJMHeagertyALaeisPSystolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertensionJ Hypertens200725102168217717885562
   PubMed Web of Science ®Google Scholar
• OgiharaTSarutaTRakugiHCombinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trialJ Hypertens201432102054206324999799
   PubMed Web of Science ®Google Scholar
• MatsuiKKim-MitsuyamaSOgawaHSex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: a subanalysis of the OSCAR studyHypertens Res201437652653224599010
   PubMed Web of Science ®Google Scholar
• SeelandURegitz-ZagrosekVSex and gender differences in cardiovascular drug therapyHandb Exp Pharmacol201221421123623027453
   PubMedGoogle Scholar
• ConroyRMPyöräläKFitzgeraldAPEstimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectEur Heart J20032411987100312788299
   PubMed Web of Science ®Google Scholar
• RoseiEAReduction of cardiovascular risk through angiotensin II type 1 receptor antagonism: focus on olmesartan medoxomilHigh Blood Press Cardiovasc Prev200815423124323355126
   PubMedGoogle Scholar
• VolpeMTocciGOlmesartan in the treatment of hypertension in elderly patients: a review of the primary evidenceDrugs Aging2013301298799824170236
   PubMed Web of Science ®Google Scholar
• CornierMADabeleaDHernandezTLThe metabolic syndromeEndocr Rev200829777782218971485
   PubMed Web of Science ®Google Scholar
• GamiASWittBJHowardDEMetabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studiesJ Am Coll Cardiol200749440341417258085
   PubMed Web of Science ®Google Scholar
• WuSHLiuZHoSCMetabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studiesEur J Epidemiol201025637538420425137
   PubMed Web of Science ®Google Scholar
• NakaoYMTeramukaiSTanakaSEffects of renin-angiotensin system blockades on cardiovascular outcomes in patients with diabetes mellitus: a systematic review and meta-analysisDiabetes Res Clin Pract2012961687522197527
   PubMed Web of Science ®Google Scholar
• PowersBGreeneLBalfeLMUpdates on the treatment of essential hypertension: a summary of AHRQ’s comparative effectiveness review of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitorsJ Manag Care Pharm2011178 SupplS1S1422088101
   PubMedGoogle Scholar
• MatcharDBMcCroryDCOrlandoLASystematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertensionAnn Intern Med20081481162917984484
   PubMed Web of Science ®Google Scholar
• AlbertiKGZimmetPShawJMetabolic syndrome – a new worldwide definition. A Consensus Statement from the International Diabetes FederationDiabet Med200623546948016681555
   PubMed Web of Science ®Google Scholar
• OmboniSMalaccoEMallionJMVolpeMAntihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly mild to moderate essential hypertensive patients with or without metabolic syndrome: a pooled post hoc analysis of two comparative trialsDrugs Aging2012291298199223179896
   PubMed Web of Science ®Google Scholar
• SharmaAMEngeliSThe role of renin-angiotensin system blockade in the management of hypertension associated with the cardiometabolic syndromeJ Cardiometab Syndr200611293517675902
   PubMedGoogle Scholar
• UngerTThe role of the renin-angiotensin system in the development of cardiovascular diseaseAm J Cardiol2002892A3A10A
   PubMed Web of Science ®Google Scholar
• PowersBJCoeytauxRRDolorRJUpdated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new informationJ Gen Intern Med201227671672922147122
   PubMed Web of Science ®Google Scholar
• MahmoodiBKMatsushitaKWoodwardMAssociations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysisLancet201238098541649166123013600
   PubMed Web of Science ®Google Scholar
• CasasJPChuaWLoukogeorgakisSEffect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysisLancet200536695022026203316338452
   PubMed Web of Science ®Google Scholar
• KunzRFriedrichCWolbersMMannJFMeta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal diseaseAnn Intern Med20081481304817984482
   PubMed Web of Science ®Google Scholar
• VejakamaPThakkinstianALertrattananonDIngsathitANgarmukosCAttiaJReno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysisDiabetologia201255356657822189484
   PubMed Web of Science ®Google Scholar
• MalaccoEOmboniSMallionJMVolpeMAntihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status: a retrospective analysisHigh Blood Press Cardiovasc Prev201219421322223430666
   PubMedGoogle Scholar
• LiuLZhangYLiuGThe Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patientsJ Hypertens200523122157217216269957
   PubMed Web of Science ®Google Scholar
• WrightJTJrFineLJLacklandDTOgedegbeGDennison HimmelfarbCREvidence supporting a systolic blood pressure goal of less than 150 mmHg in patients aged 60 years or older: the minority viewAnn Intern Med2014160749950324424788
   PubMed Web of Science ®Google Scholar
• XuWGoldbergSIShubinaMTurchinAOptimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort studyBMJ2015350h15825655523
   PubMed Web of Science ®Google Scholar
• Blood Pressure Lowering Treatment Trialists’ CollaborationTurnbullFNealBBlood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin systemJ Hypertens20072595195817414657
   PubMed Web of Science ®Google Scholar
• ThomopoulosCParatiGZanchettiAEffects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs – overview and meta-analysesJ Hypertens2015331321134126039526
   PubMed Web of Science ®Google Scholar